MIRA Pharmaceuticals Inc./$MIRA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
Ticker
$MIRA
Sector
Primary listing
Industry
Pharmaceuticals
Headquarters
Employees
-
ISIN
US60458C1045
Website
MIRA Metrics
BasicAdvanced
$21M
-
-$0.50
-
-
Price and volume
Market cap
$21M
52-week high
$1.53
52-week low
$0.73
Average daily volume
668K
Financial strength
Current ratio
12.855
Quick ratio
11.362
Profitability
Management effectiveness
Return on assets (TTM)
-193.30%
Return on equity (TTM)
-355.82%
Valuation
Price to book
16.11
Price to tangible book (TTM)
16.11
Price to free cash flow (TTM)
-3.213
Free cash flow yield (TTM)
-31.13%
Free cash flow per share (TTM)
-38.60%
Growth
Earnings per share change (TTM)
-46.91%
3-year earnings per share growth (CAGR)
21.88%
MIRA News
AllArticlesVideos
MIRA Reports Up to 30% Weight Loss and Reversal of High-Calorie and Nicotine Cravings in an Animal Model of Obesity and Craving Using SKNY-1, a Drug Candidate Under Definitive Agreement for Acquisition
Accesswire·3 days ago
MIRA Pharmaceuticals Announces New Data Underscoring Potential of SKNY-1 - A Drug Candidate Pending Acquisition - To Disrupt Weight Loss and Smoking Cessation Markets Without CNS Side Effects
Accesswire·1 week ago
MIRA Pharmaceuticals' Lead Drug Candidate Ketamir-2 First Manuscript Accepted for Publication in the Peer-Reviewed Journal Frontiers in Pharmacology
Accesswire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for MIRA Pharmaceuticals Inc. stock?
MIRA Pharmaceuticals Inc. (MIRA) has a market cap of $21M as of July 03, 2025.
What is the P/E ratio for MIRA Pharmaceuticals Inc. stock?
The price to earnings (P/E) ratio for MIRA Pharmaceuticals Inc. (MIRA) stock is 0 as of July 03, 2025.
Does MIRA Pharmaceuticals Inc. stock pay dividends?
No, MIRA Pharmaceuticals Inc. (MIRA) stock does not pay dividends to its shareholders as of July 03, 2025.
When is the next MIRA Pharmaceuticals Inc. dividend payment date?
MIRA Pharmaceuticals Inc. (MIRA) stock does not pay dividends to its shareholders.
What is the beta indicator for MIRA Pharmaceuticals Inc.?
MIRA Pharmaceuticals Inc. (MIRA) does not currently have a Beta indicator.